Inner Mongolia Jinyu Group Co., Ltd. Yangzhou AIA Biopharmaceutical Co., Ltd.

Yangzhou AIA Biopharmaceutical Co., Ltd. was invested and built by Changzhou Lihua Livestock and Poultry Co., Ltd. and Poultry Research Institute of Chinese Academy of Agricultural Sciences on June 5438+ 10, 2004. Is a high-tech enterprise specializing in the research, development, production and sales of biological products for animal disease prevention and control. The company is located in the scenic Jiangyang Industrial Park, with an area of 6 1235m2 and a total construction area of 5794m2. After the workshop was completed, it passed the GMP certification of inactivated virus vaccine embryo toxin production line in February 2005, and obtained the veterinary drug production license in June 2006. In May, 2007, Jinyu Group Co., Ltd. acquired Yangzhou AIA Biopharmaceutical Co., Ltd. by absolute holding, and carried out appropriate GMP transformation. On June 20, 2007, it passed the GMP certification of inactivated virus vaccine cell vaccine production line, which was used to produce "Inactivated Porcine Reproductive and Respiratory Syndrome Vaccine (NVDC-JXA 1 strain)". Yangzhou, with a total of 136 employees, is one of the 16 vaccine production enterprises established by the Ministry of Agriculture to produce inactivated porcine reproductive and respiratory syndrome (porcine blue ear disease).